Adam Gamsa

Adam specialises in all areas of Intellectual Property, with particular expertise in the field of patent litigation covering telecoms, computing, pharmaceutical, chemicals and medical devices disputes.

Adam’s recent cases include: a patent infringement inquiry for Neo concerning a ceric oxide chemical product and on appeal to the Court of Appeal; representing Apple at trial and on appeal (FRAND litigation brought by Optis); resisting preliminary injunctions on behalf of Mylan and Teva concerning generic pharmaceutical launches; invalidating a formulation patent for Sandoz and a dosing patent for Bayer’s rivaroxaban blood-thinning drug; appearing for R2 in their infringement claim concerning spike protection of switching converters in Intel’s processors; and representing IPCom against Vodafone in the Court of Appeal and at trial (access control in LTE/4G).

He has appeared as sole trial counsel for: (i) Tesco in its dispute with the Janger (hangers), and (ii) Technetix against Teleste (cable taps), in addition to being instructed for numerous hearings in the High Court and Court of Appeal against silks and other juniors.

After completing his doctorate in Quantum Physics at Oxford University, Adam qualified and practised as a solicitor, before being called to the bar.

Adam was nominated for the IP/IT Junior of the Year award 2020 by Chambers and Partners